OOIR: Observatory of International Research

Papers

(The H4-Index of Current Topics in Medicinal Chemistry is 25. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Bioactive Compounds Effective Against Type 2 Diabetes Mellitus: A Systematic Review	99
Recent Progress in 1H-1,2,3-triazoles as Potential Antifungal Agents	48
Emerging Proof of Protein Misfolding and Interactions in Multifactorial Alzheimer's Disease	47
Nanotechnology, A Tool for Diagnostics and Treatment of Cancer	43
A Review on Natural Sources Derived Protein Nanoparticles as Anticancer Agents	42
Coumarin-1,2,3-triazole Hybrid Molecules: An Emerging Scaffold for Combating Drug Resistance	38
An Overview of Privileged Scaffold: Quinolines and Isoquinolines in Medicinal Chemistry as Anticancer Agents	35
Eugenol as a Potential Drug Candidate: A Review	34
An Updated Review on SARS-CoV-2 Main Proteinase (MPro): Protein Structure and Small-Molecule Inhibitors	33
1,2,4-Triazole: A Privileged Scaffold for the Development of Potent Antifungal Agents - A Brief Review	33
An Update on Staphylococcus aureus NorA Efflux Pump Inhibitors	33
The Effect of Recombinant Human Interferon Alpha Nasal Drops to Prevent COVID-19 Pneumonia for Medical Staff in an Epidemic Area	33
Potential Inhibitors of Protein Tyrosine Phosphatase (PTP1B) Enzyme: Promising Target for Type-II Diabetes Mellitus	32
Garlic (Allium sativum L.): Its Chemistry, Nutritional Composition, Toxicity, and Anticancer Properties	30
Berberine: A Promising Natural Isoquinoline Alkaloid for the Development of Hypolipidemic Drugs	29
Nociceptin/Orphanin FQ Peptide Receptor-Related Ligands as Novel Analgesics	29
Shape-based Machine Learning Models for the Potential Novel COVID-19 Protease Inhibitors Assisted by Molecular Dynamics Simulation	29
The Antibacterial Activity of 1,2,3-triazole- and 1,2,4-Triazole-containing Hybrids against Staphylococcus aureus: An Updated Review (2020- Present)	29
“Big Three” Infectious Diseases: Tuberculosis, Malaria and HIV/AIDS	28
Peptide Receptor Radionuclide Therapy: Looking Back, Looking Forward	28
Resveratrol and Colorectal Cancer: A Molecular Approach to Clinical Researches	27
The Antibacterial Activity of Natural-derived Flavonoids	26
Docking Paradigm in Drug Design	26
Natural Products as Sources of Multitarget Compounds: Advances in the Development of Ferulic Acid as Multitarget Therapeutic	26
Cruzain and Rhodesain Inhibitors: Last Decade of Advances in Seeking for New Compounds Against American and African Trypanosomiases	25

Chemical and Biological Evaluation of Thiosemicarbazone-Bearing Heterocyclic Metal Complexes